Literature DB >> 14604453

Mechanisms of altered Ca2+ signalling in transformed lymphoblastoid cells from patients with bipolar disorder.

Tadafumi Kato1, Mizuho Ishiwata, Kanako Mori, Shinsuke Washizuka, Osamu Tajima, Tsuyoshi Akiyama, Nobumasa Kato.   

Abstract

Altered Ca2+ signalling has been reported in the platelets and lymphoblastoid cells of patients with bipolar disorder. Recent genetic studies have suggested possible pathophysiological roles for mitochondria and endoplasmic reticulum, both of which are essential for the regulation of intracellular Ca2+ signalling. The goal of this study was to determine molecular mechanisms of altered intracellular Ca2+ signalling in bipolar disorder. Lymphoblastoid cell lines were established from patients with bipolar I disorder (n=13) and controls (n=11). Using Ca2+ indicators, cytosolic and mitochondrial Ca2+ responses to the following three reagents were examined: platelet-activating factor; carbonyl cyanide m-chlorophenylhydrazone (CCCP), a mitochondrial uncoupler that abolishes mitochondrial Ca2+ uptake; and thapsigargin, an endoplasmic reticulum Ca2+ pump inhibitor. The 10-5 M thapsigargin-induced cytosolic Ca2+ response was significantly higher in patients with bipolar disorder (p&0.05). Such difference was not seen when the effects of Ca2+ influx from outside the plasma membrane was eliminated using Ca2+-free measurement buffer. On the other hand, response to 10-7 M thapsigargin tended to be higher in patients with bipolar disorder when at the Ca2+-free conditions. CCCP-induced Ca2+ responses differed significantly between mitochondrial DNA 5178/10398 haplotypes (p=0.001) that had been previously reported to be associated with bipolar disorder. These results suggest that all components, i.e. the store-operated calcium channel (SOCC), endoplasmic reticulum, and mitochondria, somehow contribute to the altered Ca2+ signalling in bipolar disorder.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14604453     DOI: 10.1017/S1461145703003717

Source DB:  PubMed          Journal:  Int J Neuropsychopharmacol        ISSN: 1461-1457            Impact factor:   5.176


  18 in total

Review 1.  Multiple levels of impaired neural plasticity and cellular resilience in bipolar disorder: developing treatments using an integrated translational approach.

Authors:  Rodrigo Machado-Vieira; Marcio G Soeiro-De-Souza; Erica M Richards; Antonio L Teixeira; Carlos A Zarate
Journal:  World J Biol Psychiatry       Date:  2013-09-02       Impact factor: 4.132

2.  Comprehensive DNA methylation analysis of human peripheral blood leukocytes and lymphoblastoid cell lines.

Authors:  Hiroko Sugawara; Kazuya Iwamoto; Miki Bundo; Junko Ueda; Jun Ishigooka; Tadafumi Kato
Journal:  Epigenetics       Date:  2011-04-01       Impact factor: 4.528

Review 3.  Use of peripheral blood transcriptome biomarkers for epilepsy prediction.

Authors:  Stanislav L Karsten; Lili C Kudo; Anatol J Bragin
Journal:  Neurosci Lett       Date:  2011-03-17       Impact factor: 3.046

4.  Rare variants in neuronal excitability genes influence risk for bipolar disorder.

Authors:  Seth A Ament; Szabolcs Szelinger; Gustavo Glusman; Justin Ashworth; Liping Hou; Nirmala Akula; Tatyana Shekhtman; Judith A Badner; Mary E Brunkow; Denise E Mauldin; Anna-Barbara Stittrich; Katherine Rouleau; Sevilla D Detera-Wadleigh; John I Nurnberger; Howard J Edenberg; Elliot S Gershon; Nicholas Schork; Nathan D Price; Richard Gelinas; Leroy Hood; David Craig; Francis J McMahon; John R Kelsoe; Jared C Roach
Journal:  Proc Natl Acad Sci U S A       Date:  2015-02-17       Impact factor: 11.205

5.  The somatic common deletion in mitochondrial DNA is decreased in schizophrenia.

Authors:  Firoza Mamdani; Brandi Rollins; Ling Morgan; P Adolfo Sequeira; Marquis P Vawter
Journal:  Schizophr Res       Date:  2014-09-28       Impact factor: 4.939

6.  Emerging Novel Treatments for Severe Mood Disorders Involving Cellular Plasticity Cascades.

Authors:  Rodrigo Machado-Vieira; Carlos A Zarate; Husseini K Manji
Journal:  Curr Psychos Ther Rep       Date:  2006-12

Review 7.  Mitochondrial dysfunction and pathology in bipolar disorder and schizophrenia.

Authors:  Hayley B Clay; Stephanie Sillivan; Christine Konradi
Journal:  Int J Dev Neurosci       Date:  2010-09-15       Impact factor: 2.457

8.  Effect of mood stabilizers on gene expression in lymphoblastoid cells.

Authors:  Hiroko Sugawara; Kazuya Iwamoto; Miki Bundo; Mizuho Ishiwata; Junko Ueda; Chihiro Kakiuchi; Jun Ishigooka; Tadafumi Kato
Journal:  J Neural Transm (Vienna)       Date:  2009-12-01       Impact factor: 3.575

9.  Association analysis of HSP90B1 with bipolar disorder.

Authors:  Chihiro Kakiuchi; Mizuho Ishiwata; Shinichiro Nanko; Hiroshi Kunugi; Yoshio Minabe; Kazuhiko Nakamura; Norio Mori; Kumiko Fujii; Tadashi Umekage; Mamoru Tochigi; Kazuhisa Kohda; Tsukasa Sasaki; Kazuo Yamada; Takeo Yoshikawa; Tadafumi Kato
Journal:  J Hum Genet       Date:  2007-09-04       Impact factor: 3.172

Review 10.  Targeting mitochondrially mediated plasticity to develop improved therapeutics for bipolar disorder.

Authors:  Rafael T de Sousa; Rodrigo Machado-Vieira; Carlos A Zarate; Husseini K Manji
Journal:  Expert Opin Ther Targets       Date:  2014-07-24       Impact factor: 6.902

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.